The 8th GPCR iHuman Forum was held at the ShanghaiTech University Conference Center from October 18th to 20th, 2023. The cofounder of AlphaMol, Dr. Shuguang Yuan, was invited to this event to give a presentation.

Recently, AlphaMol received milestone payments from both Shanghai Pharma and Salubris Pharma for the co-developing orphan GPCR drug discovery pipeline.

The paper enttiled "Advancing Drug Discovery via Artificial Intelligence" by the team member of AlphaMol has been in the list of Highly Cited Article (HCA). The total citation of this work is over 310 times by April 2023. 

By resolving the 3D structure of this important target Panx2 coupled with computational simulations, the molecular mechanisms were illuminated which could guide Panx2-based drug discovery for brain cancer.  

The cofounders of AlphaMol Dr. Horst Vogel and Dr. Shuguang Yuan are among World’s Top 2% Scientists in the 2022 list. 

AlphaMol presented in the international GPCR conference

AlphaMol Science has obtained the top outstanding award from NVIDIA Inception contest program.